Clinical Trial: Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chronic Lymphocytic Leukemia
Clinical Trial: Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chronic Lymphocytic LeukemiaSponsor and Collaborators
Arthur G. James Cancer Hospital & Richard J. Solove Research Institute
National Cancer Institute (NCI)
Contact
Contact: Clinical Trials Office - Cincinnati Children's Hospital Medica
(513)-636-2799
Principal Investigator
Thomas E. Olencki, DO
Arthur G. James Cancer Hospital & Richard J. Solove Research Institute
ClinicalTrials.gov Identifier
NCT00563290
